GERM
Amplify Treatments, Testing and Advancements ETF
GERM
GERM
Delisted
GERM was delisted on the 5th of September, 2024.
30 hedge funds and large institutions have $9.18M invested in Amplify Treatments, Testing and Advancements ETF in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
30
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$769K | |
| 2 | +$201K | |
| 3 | +$48.8K | |
| 4 |
CHC
City Holding Co
Charleston,
West Virginia
|
+$11K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$7.9K |
Top Sellers
| 1 | -$347K | |
| 2 | -$246K | |
| 3 | -$124K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$121K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$111K |